Detecting p53 Aggregates for Cancer Diagnosis
p53 is a key tumour suppressor prone to aggregation, a process that impairs its function and may drive cancer progression. We developed an ultrasensitive blood-based assay to detect p53 aggregates, revealing their potential as a novel biomarker for glioblastoma.